NASDAQ: ENTAEnanta Pharmaceuticals Inc Stock Ownership - Who owns Enanta Pharmaceuticals?
Insider buying vs selling
Have Enanta Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jay R. Luly | President and CEO | 2025-02-12 | 7,484 | $5.59 | $41.84kSell |
| Paul J. Mellett | Chief Fin. Admin Officer | 2025-02-12 | 3,326 | $5.59 | $18.59kSell |
| Tara Lynn Kieffer | Chief Product Strategy Officer | 2025-02-12 | 3,326 | $5.59 | $18.59kSell |
| Brendan Luu | Chief Business Officer | 2025-02-12 | 3,326 | $5.59 | $18.59kSell |
| Yat Sun Or | Chief Scientific Officer | 2025-02-12 | 4,324 | $5.59 | $24.17kSell |
| Scott T. Rottinghaus | Chief Medical Officer | 2025-02-12 | 2,861 | $5.59 | $15.99kSell |
| Jay R. Luly | President and CEO | 2025-02-12 | 45,000 | $5.69 | $256.05kBuy |
| Paul J. Mellett | Chief Fin. Admin Officer | 2024-12-06 | 2,591 | $8.06 | $20.88kSell |
| Tara Lynn Kieffer | Chief Product Strategy Officer | 2024-12-06 | 2,283 | $8.06 | $18.40kSell |
| Jay R. Luly | President and CEO | 2024-12-06 | 5,142 | $8.06 | $41.44kSell |
ENTA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ENTA insiders and whales buy or sell their stock.
ENTA Shareholders
What type of owners hold Enanta Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Helmut Schuhsler | 27.01% | 5,761,609 | $33.36M | Insider |
| Saints Capital Granite LP | 16.40% | 3,497,683 | $20.25M | Insider |
| Krensavage Asset Management LLC | 9.93% | 2,117,390 | $12.26M | Institution |
| Farallon Capital Management LLC | 9.88% | 2,108,262 | $12.21M | Institution |
| Blackrock Inc | 9.56% | 2,039,642 | $11.81M | Institution |
| Vanguard Group Inc | 9.30% | 1,984,164 | $11.49M | Institution |
| Shionogi Co Ltd | 7.50% | 1,599,760 | $9.26M | Insider |
| Morgan Stanley | 5.73% | 1,221,595 | $7.07M | Institution |
| Tvm V Life Science Ventures Gmbh Co Kg | 5.37% | 1,144,932 | $6.63M | Insider |
| Ra Capital Management LP | 4.87% | 1,038,000 | $6.01M | Institution |
ENTA vs Biotech Stocks
Enanta Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.